MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Ultra-Low Radiation Dose, Prospectively Gated Coronary CTA
State-of-the-art coronary CTA is now possible with radiation exposure less than that of a calcium score.
By David A. Dowe, MD
Multivessel Interventions
By Ted E. Feldman, MD, Chief Medical Editor
SAVR Versus TAVR: Treating Intermediate-Risk Patients
A patient-centered debate on the safety, efficacy, and durability of transcatheter aortic valve replacement versus surgical aortic valve replacement for intermediate-risk patients.
With Bruce Rutkin, MD; S. Jacob Scheinerman, MD, FACS; and Issam D. Moussa, MD, MBA
Pathophysiology and Therapy for Atrial Septal Defects
An overview of this common congenital anomaly and the options for surveillance and treatment.
By Mary Shields, MD; Maria Baldasare, MD; David Goldberg, MD; Awail Sadiq, MD; and Sheldon Goldberg, MD, FACC, FSCAI
ISET Panel Considers Future of Renal Denervation to Treat Hypertension
February 2, 2015—A panel at ISET 2015: the International Symposium on Endovascular Therapy in Hollywood, Florida, discussed the past and future investigations of renal denervation (RDN) as therapy for treatment-resistant hypertension (HTN).
CTA-Derived Coronary FFR: The “Holy Grail” of Noninvasive Imaging?
FFRCT technology allows new diagnostic opportunities by combining the assessment of anatomy and physiology.
By Frederick St. Goar, MD; James Min, MD; Bon-Kwon Koo, MD; and Charles Taylor, PhD
SCAI Issues Statement on the Association of Paclitaxel Devices and Mortality
January 25, 2019—The Society for Cardiovascular Angiography and Interventions (SCAI) has issued a statement on the recent study of the association between paclitaxel-eluting devices and mortality.
Managing Paravalvular Leaks After TAVR
Will next-generation percutaneous valve technologies address this current limitation?
By Satpal S. Arri, BSc, MRCP, and David Hildick-Smith, MD, FRCP
Guidelines for STEMI
Key messages from the ACC/AHA/SCAI 2009 focused update for the management of ST-elevation myocardial infarction.
By Jeffery M. Sparling, MD; Pinak B. Shah, MD; and David O. Williams, MD
Mount Sinai Study Finds Anticoagulants May Improve Survival in Hospitalized COVID-19 Patients
May 6, 2020—The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai in New York, New York, announced the publication of a research letter from the Mount Sinai COVID Informatics Center reporting that treating hospitalized COVID-19 patients with anticoagulants may improve their chances of survival.
ACC/AHA/SCAI Release Revised PCI Guideline
November 7, 2011—The American College of Cardiology Foundation (ACCF), American Heart Association (AHA), and Society for Cardiovascular Angiography and Interventions (SCAI) have released a revised guideline for the management of patients undergoing percutaneous coronary intervention (PCI).
Xience V (Promus) Drug-Eluting Coronary Stent
Design features, preclinical data, and clinical outcomes.
By Krishna Sudhir, MD, PhD, FRACP, FACC; David R. Rutledge, Pharm D, FAHA, FCCP; Alena Pechonkina, MD; and Chuck Simonton, MD, FACC, FSCAI
Postapproval Study Supports Safety and Efficacy of CardioMEMS Sensor
March 17, 2019—The American College of Cardiology (ACC) announced that findings from the postapproval study for the CardioMEMS heart failure sensor (Abbott Vascular) were presented by David Shavelle, MD, at the ACC's 68th Annual Scientific Session, being held March 16–18 in New Orleans, Louisiana.
BioCardia’s CardiAMP Cell Therapy Heart Failure Trial Reports Interim Data
March 4, 2024—BioCardia, Inc. announced positive interim results from the phase 3 randomized controlled trial of its CardiAMP autologous cell therapy, which uses a patient’s own bone marrow cells delivered to the heart in a catheter-based procedure to potentially stimulate the body’s natural healing response.
COVID-PACT Trial Supports Full-Dose Anticoagulation to Prevent Blood Clots in COVID-19 Patients
August 29, 2022—The European Society of Cardiology (ESC) announced study findings that suggest treatment of critically ill COVID-19 patients with full-dose anticoagulation lowers the risk of venous and arterial clotting complications by 44% compared with the standard dose.
Heart Failure Patients Fare Better With Catheter Ablation Versus Amiodarone Treatment
March 16, 2015—The American College of Cardiology (ACC) announced the presentation of results from the AATAC (Ablation vs Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device) multicenter randomized trial at the 64th annual scientific session of the ACC in San Diego, California. The study’s Lead Investigator is Luigi Di Biase, MD, who is a cardiologist and electrophysiologist at St.
Next-Generation Transcatheter Aortic Valves
A preview of the latest devices that are expected to change the practice of transcatheter valve replacement.
By Ehrin J. Armstrong, MD, MSc, and Jason H. Rogers, MD
An Interview With David G. Rizik, MD
How upcoming technology, devices, and research will benefit the interventional cardiology community.
Rotational Ablation as a Bailout Technique
How to facilitate expansion of a severely underexpanded stent.
By David J. James, md; S. Chiu Wong, MD; and Issam D. Moussa, MD
Catheter-Based Tricuspid Intervention
A review of current leaflet, annular, and valve replacement device technologies.
By Abdellaziz Dahou, MD, PhD; Juan F. Granada, MD; and Rebecca T. Hahn, MD
